- Home
- SUPN vs EFSC Comparison
SUPN vs EFSC Comparison
Compare SUPN & EFSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SUPN | EFSC |
|---|---|---|
| Founded | 2005 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.1B |
| IPO Year | 2014 | 1996 |
Fundamental Metrics
Financial Performance| Metric | SUPN | EFSC |
|---|---|---|
| Price | $26.85 | $62.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $60.50 | ★ $69.57 |
| AVG Volume (30 Days) | ★ 1.7M | 209.2K |
| Earning Date | 10-29-2026 | 10-21-2026 |
| Dividend Yield | N/A | ★ 2.25% |
| EPS Growth | ★ 8100.00 | 9.94 |
| EPS | 2.78 | ★ 3.54 |
| Revenue | ★ $1,239,000,000.00 | N/A |
| Revenue This Year | $23.01 | $2.97 |
| Revenue Next Year | $15.28 | $6.98 |
| P/E Ratio | ★ N/A | $18.04 |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $26.74 | $51.18 |
| 52 Week High | $59.68 | $68.73 |
Technical Indicators
Market Signals| Indicator | SUPN | EFSC |
|---|---|---|
| Relative Strength Index (RSI) | 19.93 | 66.07 |
| Support Level | N/A | $63.58 |
| Resistance Level | $51.59 | $64.93 |
| Average True Range (ATR) | 2.21 | 1.24 |
| MACD | -1.14 | 0.42 |
| Stochastic Oscillator | 8.37 | 87.52 |
Price Performance
Historical ComparisonAbout SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.
About EFSC Enterprise Financial Services Corporation
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Its Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.